Compounds > azides
Page last updated: 2024-08-23

azides and HIV

azides has been researched along with HIV in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brouwer, AJ; Kruijtzer, JA; Liskamp, RM; Mulder, GE; Quarles van Ufford, HL; van Ameijde, J1
Chang, JB; Chen, H; Cui, XQ; Dai, SX; Huang, JF; Liu, YJ; Luo, RH; Peng, YM; Wang, RR; Yang, QH; Zhang, XJ; Zheng, YT1
Burke, TR; Johnson, AA; Karki, RG; Marchand, C; Nicklaus, MC; Pais, GC; Pathak, VK; Pommier, Y; Svarovskaia, ES; Zhang, X1
Bess, JW; Blumenthal, R; Chertova, E; Raviv, Y; Viard, M1
Balzarini, J; Bonache, MC; Camarasa, MJ; Pérez-Pérez, MJ; Quesada, E; San-Félix, A; Sheen, CW; Sluis-Cremer, N1
Kim, H; Parthasarathy, R1

Other Studies

6 other study(ies) available for azides and HIV

ArticleYear
Scaffold optimization in discontinuous epitope containing protein mimics of gp120 using smart libraries.
    Organic & biomolecular chemistry, 2013, Apr-28, Volume: 11, Issue:16

    Topics: Alkynes; Amino Acid Sequence; Azides; Catalysis; Copper; Cycloaddition Reaction; Epitopes; HIV; HIV Envelope Protein gp120; HIV Infections; Humans; Models, Molecular; Molecular Sequence Data; Peptide Library; Peptides, Cyclic; Protein Binding; Solid-Phase Synthesis Techniques; Vaccines, Synthetic

2013
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Anti-HIV Agents; Azides; Cell Line; Deoxycytidine; Drug Resistance, Viral; Genotype; HIV; HIV Reverse Transcriptase; Humans; Lamivudine; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Protein Binding; Reverse Transcriptase Inhibitors; Virus Replication

2014
Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors.
    Bioorganic & medicinal chemistry letters, 2003, Mar-24, Volume: 13, Issue:6

    Topics: Anti-HIV Agents; Azides; Cell Line; Cell Survival; HIV; HIV Integrase; HIV Integrase Inhibitors; Humans; Indicators and Reagents; Keto Acids; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Molecular Conformation; Recombinant Proteins; Structure-Activity Relationship

2003
Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope.
    Journal of virology, 2005, Volume: 79, Issue:19

    Topics: Antibodies, Monoclonal; Antiviral Agents; Azides; Cell Fusion; Chromatography, High Pressure Liquid; HIV; Hydrophobic and Hydrophilic Interactions; Nucleocapsid Proteins; Retroviridae; Simian Immunodeficiency Virus; Viral Envelope Proteins; Virus Inactivation

2005
Novel N-3 substituted TSAO-T derivatives: synthesis and anti-HIV-evaluation.
    Nucleosides, nucleotides & nucleic acids, 2008, Volume: 27, Issue:4

    Topics: Azides; Benzophenones; Cell Line; Drug Design; HIV; HIV Reverse Transcriptase; HIV-1; HIV-2; Protein Binding; Reverse Transcriptase Inhibitors; Spiro Compounds; Substrate Specificity; Thymidine; Ultraviolet Rays; Uridine; Virus Replication

2008
Conformation and sandwiching of bases by azido groups in the crystal structure of 3'-azido-3'-deoxy-thymidine (AZT), an antiviral agent that inhibits HIV reverse transcriptase.
    Biochemical and biophysical research communications, 1988, Apr-15, Volume: 152, Issue:1

    Topics: Azides; Dideoxynucleotides; HIV; Hydrogen Bonding; Models, Molecular; Molecular Conformation; Reverse Transcriptase Inhibitors; Thymine Nucleotides; Zidovudine

1988